• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化急性失代偿住院患者的全身炎症反应综合征。

Systemic Inflammatory Response Syndrome in Patients Hospitalized for Acute Decompensation of Cirrhosis.

机构信息

Division of Gastroenterology, Department of Internal Medicine, Federal University of Santa Catarina, Florianópolis, Santa Catarina, Brazil.

Department of Gastroenterology and Hepatology, Bonsucesso Federal Hospital, Rio de Janeiro, Brazil.

出版信息

Can J Gastroenterol Hepatol. 2021 Apr 25;2021:5581587. doi: 10.1155/2021/5581587. eCollection 2021.

DOI:10.1155/2021/5581587
PMID:33987144
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8093053/
Abstract

BACKGROUND

Although recently challenged, systemic inflammatory response syndrome (SIRS) criteria are still commonly used in daily practice to define sepsis. However, several factors in liver cirrhosis may negatively impact its prognostic ability. . To investigate the factors associated with the presence of SIRS, the characteristics of SIRS related to infection, and its prognostic value among patients hospitalized for acute decompensation of cirrhosis. . In this cohort study from two tertiary hospitals, 543 patients were followed up, up to 90 days. Data collection, including the prognostic models, was within 48 hours of admission.

RESULTS

SIRS was present in 42.7% of the sample and was independently associated with upper gastrointestinal bleeding (UGB), ACLF, infection, and negatively related to beta-blockers. SIRS was associated with mortality in univariate analysis, but not in multiple Cox regression analysis. The Kaplan-Meier survival probability of patients without SIRS was 73.0% and for those with SIRS was 64.7%. The presence of SIRS was not significantly associated with mortality when considering patients with or without infection, separately. Infection in SIRS patients was independently associated with Child-Pugh C and inversely related to UGB. Among subjects with SIRS, mortality was independently related to the presence of infection, ACLF, and Child-Pugh C.

CONCLUSIONS

SIRS was common in hospitalized patients with cirrhosis and was of no prognostic value, even in the presence of infection.

摘要

背景

尽管最近受到了挑战,全身炎症反应综合征(SIRS)标准仍在日常实践中广泛用于定义脓毒症。然而,肝硬化的几个因素可能会对其预后能力产生负面影响。。本研究旨在调查与 SIRS 存在相关的因素、与感染相关的 SIRS 特征,以及在因肝硬化急性失代偿而住院的患者中的预后价值。。在这两项来自两所三级医院的队列研究中,对 543 例患者进行了随访,最长随访时间为 90 天。数据收集,包括预后模型,均在入院后 48 小时内完成。

结果

样本中存在 SIRS 的比例为 42.7%,其与上消化道出血(UGB)、ACLF、感染独立相关,且与β受体阻滞剂呈负相关。SIRS 在单变量分析中与死亡率相关,但在多变量 Cox 回归分析中不相关。无 SIRS 的患者的 Kaplan-Meier 生存概率为 73.0%,而有 SIRS 的患者为 64.7%。在分别考虑有或无感染的患者时,SIRS 的存在与死亡率无显著相关性。SIRS 患者的感染与 Child-Pugh C 独立相关,与 UGB 呈负相关。在存在 SIRS 的患者中,死亡率与感染、ACLF 和 Child-Pugh C 的存在独立相关。

结论

在住院的肝硬化患者中,SIRS 很常见,但其预后价值有限,即使在存在感染的情况下也是如此。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8fe/8093053/31be67c3dc0f/CJGH2021-5581587.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8fe/8093053/bc060a81ad1f/CJGH2021-5581587.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8fe/8093053/90d264257a28/CJGH2021-5581587.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8fe/8093053/31be67c3dc0f/CJGH2021-5581587.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8fe/8093053/bc060a81ad1f/CJGH2021-5581587.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8fe/8093053/90d264257a28/CJGH2021-5581587.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8fe/8093053/31be67c3dc0f/CJGH2021-5581587.003.jpg

相似文献

1
Systemic Inflammatory Response Syndrome in Patients Hospitalized for Acute Decompensation of Cirrhosis.肝硬化急性失代偿住院患者的全身炎症反应综合征。
Can J Gastroenterol Hepatol. 2021 Apr 25;2021:5581587. doi: 10.1155/2021/5581587. eCollection 2021.
2
[Systemic inflammatory response syndrome as prognostic indicator in hospitalized cirrhotic patients].[全身炎症反应综合征作为住院肝硬化患者的预后指标]
Rev Gastroenterol Peru. 2014 Jul;34(3):211-6.
3
Systemic inflammatory response syndrome in patients hospitalized for gastrointestinal bleeding.因胃肠道出血住院患者的全身炎症反应综合征
Crit Care Med. 1999 Mar;27(3):554-7. doi: 10.1097/00003246-199903000-00035.
4
Clinical characteristics and prognostic factors of liver cirrhosis patients with systemic inflammatory response syndrome.伴有全身炎症反应综合征的肝硬化患者的临床特征及预后因素
Hepatol Res. 2017 Oct;47(11):1174-1185. doi: 10.1111/hepr.12886. Epub 2017 May 19.
5
Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure.终末期肝病评分模型和全身炎症反应是肝硬化合并急性功能性肾衰竭患者的主要预后因素。
Hepatology. 2007 Dec;46(6):1872-82. doi: 10.1002/hep.21920.
6
The usefulness of C-reactive protein and neutrophil-to-lymphocyte ratio for predicting the outcome in hospitalized patients with liver cirrhosis.C反应蛋白和中性粒细胞与淋巴细胞比值对预测肝硬化住院患者预后的价值
BMC Gastroenterol. 2015 Oct 23;15:146. doi: 10.1186/s12876-015-0378-z.
7
Incidence and Prognostic Value of the Systemic Inflammatory Response Syndrome and Organ Dysfunctions in Ward Patients.病房患者全身炎症反应综合征和器官功能障碍的发生率及预后价值
Am J Respir Crit Care Med. 2015 Oct 15;192(8):958-64. doi: 10.1164/rccm.201502-0275OC.
8
Upper gastrointestinal bleeding in patients with hepatic cirrhosis: clinical course and mortality prediction.肝硬化患者的上消化道出血:临床病程及死亡预测
Am J Gastroenterol. 2000 Feb;95(2):484-9. doi: 10.1111/j.1572-0241.2000.01772.x.
9
Systemic inflammatory response syndrome in patients with liver cirrhosis.肝硬化患者的全身炎症反应综合征
Arab J Gastroenterol. 2011 Dec;12(4):173-7. doi: 10.1016/j.ajg.2011.11.006. Epub 2011 Dec 20.
10
The systemic inflammatory response syndrome in cirrhotic patients: relationship with their in-hospital outcome.肝硬化患者的全身炎症反应综合征:与住院结局的关系。
J Hepatol. 2009 Sep;51(3):475-82. doi: 10.1016/j.jhep.2009.04.017. Epub 2009 May 26.

引用本文的文献

1
Correlation between systemic inflammatory response syndrome and prognosis of patients with cirrhosis and hepatic encephalopathy.系统性炎症反应综合征与肝硬化合并肝性脑病患者预后的相关性
BMC Gastroenterol. 2025 Jul 28;25(1):536. doi: 10.1186/s12876-025-04141-1.
2
Sepsis in liver failure patients: Diagnostic challenges and recent advancements.肝功能衰竭患者的脓毒症:诊断挑战与最新进展
World J Crit Care Med. 2025 Jun 9;14(2):101587. doi: 10.5492/wjccm.v14.i2.101587.
3
Serial Procalcitonin Measurements for Determining Bacterial Infection and Mortality in Cirrhotic Patients With Systemic Inflammatory Response Syndrome.

本文引用的文献

1
Clinical Consequences of Infection in Cirrhosis: Organ Failures and Acute-on-Chronic Liver Failure.肝硬化感染的临床后果:器官衰竭与慢加急性肝衰竭
Clin Liver Dis (Hoboken). 2019 Oct 9;14(3):92-97. doi: 10.1002/cld.813. eCollection 2019 Sep.
2
Infections in Cirrhosis.肝硬化中的感染
Curr Treat Options Gastroenterol. 2019 Jun;17(2):254-270. doi: 10.1007/s11938-019-00229-2.
3
Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide.全球肝硬化患者细菌感染的流行病学和影响。
连续检测降钙素原用于确定伴有全身炎症反应综合征的肝硬化患者的细菌感染及死亡率
Clin Transl Gastroenterol. 2025 Mar 1;16(3):e00810. doi: 10.14309/ctg.0000000000000810.
4
Is the SIRS Criteria a Good Predictor of Blood stream Infection in Cirrhosis? A Single-Center Retrospective Analysis.全身炎症反应综合征(SIRS)标准能否有效预测肝硬化患者的血流感染?一项单中心回顾性分析。
Am J Med Open. 2023 Aug 2;10:100052. doi: 10.1016/j.ajmo.2023.100052. eCollection 2023 Dec.
5
Novel predictors of response to therapy with terlipressin and albumin in hepatorenal syndrome-acute kidney injury.肝肾综合征-急性肾损伤中特利加压素与白蛋白治疗反应的新型预测指标
Ann Gastroenterol. 2024 Jan-Feb;37(1):81-88. doi: 10.20524/aog.2023.0853. Epub 2023 Dec 23.
6
Scoring system for predicting 90-day mortality of in-hospital liver cirrhosis patients at Cipto Mangunkusumo Hospital.预测 Cipto Mangunkusumo 医院住院肝硬化患者 90 天死亡率的评分系统。
BMC Gastroenterol. 2023 Jun 1;23(1):190. doi: 10.1186/s12876-023-02813-4.
7
Prognostic performance of the REDS score, SOFA score, NEWS2 score, and the red-flag, NICE high-risk, and SIRS criteria to predict survival at 180 days, in emergency department patients admitted with suspected sepsis - An observational cohort study.REDS评分、序贯器官衰竭评估(SOFA)评分、国家早期预警评分2(NEWS2)以及红旗标准、英国国家卫生与临床优化研究所(NICE)高危标准和全身炎症反应综合征(SIRS)标准对疑似脓毒症的急诊科住院患者180天生存率的预测效能——一项观察性队列研究
Front Med (Lausanne). 2023 Mar 14;10:985444. doi: 10.3389/fmed.2023.985444. eCollection 2023.
Gastroenterology. 2019 Apr;156(5):1368-1380.e10. doi: 10.1053/j.gastro.2018.12.005. Epub 2018 Dec 13.
4
Applicability of Sepsis-3 criteria and quick Sequential Organ Failure Assessment in patients with cirrhosis hospitalised for bacterial infections.Sepsis-3 标准和快速序贯器官衰竭评估在肝硬化合并细菌感染住院患者中的适用性。
Liver Int. 2019 Feb;39(2):307-315. doi: 10.1111/liv.13980. Epub 2018 Dec 4.
5
Systemic inflammatory response syndrome and model for end-stage liver disease score accurately predict the in-hospital mortality of black African patients with decompensated cirrhosis at initial hospitalization: a retrospective cohort study.全身炎症反应综合征和终末期肝病模型评分可准确预测非洲黑人失代偿期肝硬化患者初次住院时的院内死亡率:一项回顾性队列研究
Clin Exp Gastroenterol. 2018 Apr 9;11:143-152. doi: 10.2147/CEG.S140655. eCollection 2018.
6
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis.欧洲肝脏研究学会失代偿期肝硬化患者管理临床实践指南
J Hepatol. 2018 Aug;69(2):406-460. doi: 10.1016/j.jhep.2018.03.024. Epub 2018 Apr 10.
7
NACSELD acute-on-chronic liver failure (NACSELD-ACLF) score predicts 30-day survival in hospitalized patients with cirrhosis.NACSELD 慢加急性肝衰竭(NACSELD-ACLF)评分可预测住院肝硬化患者的 30 天生存率。
Hepatology. 2018 Jun;67(6):2367-2374. doi: 10.1002/hep.29773. Epub 2018 Apr 19.
8
SIRS in the Time of Sepsis-3.Sepsis-3 时代的全身炎症反应综合征(SIRS)。
Chest. 2018 Jan;153(1):34-38. doi: 10.1016/j.chest.2017.10.006. Epub 2017 Oct 14.
9
Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections.肝硬化合并细菌感染患者中 Sepsis-3 标准和快速 SOFA 的评估。
Gut. 2018 Oct;67(10):1892-1899. doi: 10.1136/gutjnl-2017-314324. Epub 2017 Aug 31.
10
Clinical characteristics and prognostic factors of liver cirrhosis patients with systemic inflammatory response syndrome.伴有全身炎症反应综合征的肝硬化患者的临床特征及预后因素
Hepatol Res. 2017 Oct;47(11):1174-1185. doi: 10.1111/hepr.12886. Epub 2017 May 19.